TRYVIO is a prescription medication used in combination with other drugs to treat high blood pressure that is not adequately controlled by other treatments.
TRYVIO™ (aprocitentan) is an endothelin receptor antagonist (ERA) indicated for the treatment of hypertension in patients who are not adequately controlled on other drugs. It is designed to be used in combination with other blood pressure-lowering medications. As a specialized prescription medicine, it requires careful administration, monitoring, and precise adherence to safety instructions.
Because of the potential risk of serious birth defects, TRYVIO is available only through a restricted distribution program called the TRYVIO Risk Evaluation and Mitigation Strategy (REMS). Patients, prescribers, and pharmacies must follow strictly defined protocols, including pregnancy testing and acceptable birth control measures, to ensure safety while providing or undergoing treatment. For comprehensive product information, patient guides, and safety procedures, reference the official TRYVIO REMS materials and manuals.
Najnovejši priročniki od manuals+ izbrano za to blagovno znamko.
Pogosta vprašanja o priročnikih, registraciji in podpori za to blagovno znamko.
TRYVIO (aprocitentan) is a prescription medicine used in combination with other blood pressure-lowering medications for the treatment of high blood pressure that is not adequately controlled on other drugs.
TRYVIO can cause serious birth defects if taken during pregnancy. You must not take TRYVIO if you are pregnant, and you must not become pregnant while taking it or for one month after stopping treatment.
The Risk Evaluation and Mitigation Strategy (REMS) is an FDA-required safety program for TRYVIO to manage the risk of serious birth defects. Patients must enroll, undergo pregnancy testing, and use acceptable birth control.
TRYVIO is only available through certified pharmacies participating in the TRYVIO REMS program. It cannot be dispensed by non-certified pharmacies.
For support regarding the REMS program enrollment, reporting, or procedures, you can visit www.tryviorems.com or call 1-866-429-8964.